Literature DB >> 1336827

Glutathione: new candidate neuropeptide in the central nervous system.

N Guo1, C McIntosh, C Shaw.   

Abstract

The physiological significance of glutathione in the mammalian central nervous system is still uncertain, although some evidence indicates that it may be an important regulatory peptide. In the present study, the distribution and characteristics of glutathione binding sites in the brain have been studied. Biotinyl-glutathione was synthesized as a probe to detect glutathione binding sites in the CNS. Specific glutathione binding sites in the brain were largely localized to the white matter, suggesting the presence of glutathione receptors on neuroglial cells. The colloidal gold technique and immunofluorescence double staining allowed the visualization of the receptor at the cellular level and thus demonstrated that there are glutathione receptors on cultured astrocytes. Glutathione applied to cultured astrocytes elicited increased levels of intracellular inositol-1,4,5-trisphosphate, suggesting that glutathione receptors were coupled to phospholipase C. The localization of glutathione receptors on astrocytes and the activation of a second messenger system by glutathione suggest that glutathione may be a neuropeptide in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336827     DOI: 10.1016/0306-4522(92)90524-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

1.  Glutathione is an endogenous ligand of rat brain N-methyl-D-aspartate (NMDA) and 2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors.

Authors:  V Varga; Z Jenei; R Janáky; P Saransaari; S S Oja
Journal:  Neurochem Res       Date:  1997-09       Impact factor: 3.996

2.  The gamma-glutamyl transpeptidase inhibitor acivicin preserves glutathione released by astroglial cells in culture.

Authors:  R Dringen; O Kranich; B Hamprecht
Journal:  Neurochem Res       Date:  1997-06       Impact factor: 3.996

3.  Cardiovascular responses to l-glutamate microinjection into the NTS are abrogated by reduced glutathione.

Authors:  Álisson Silva Granato; Paula Magalhães Gomes; Renato William Martins Sá; Gabriel Silva Marques Borges; Andréia Carvalho Alzamora; Lisandra Brandino de Oliveira; Glenn M Toney; Leonardo M Cardoso
Journal:  Neurosci Lett       Date:  2017-02-09       Impact factor: 3.046

4.  Dynamic or inert metabolism? Turnover of N-acetyl aspartate and glutathione from D-[1-13C]glucose in the rat brain in vivo.

Authors:  In-Young Choi; Rolf Gruetter
Journal:  J Neurochem       Date:  2004-11       Impact factor: 5.372

5.  A randomized, double-blind phase I/IIa study of intranasal glutathione in Parkinson's disease.

Authors:  Laurie K Mischley; James B Leverenz; Richard C Lau; Nayak L Polissar; Moni B Neradilek; Ali Samii; Leanna J Standish
Journal:  Mov Disord       Date:  2015-07-31       Impact factor: 10.338

Review 6.  Glutathione dysregulation and the etiology and progression of human diseases.

Authors:  Nazzareno Ballatori; Suzanne M Krance; Sylvia Notenboom; Shujie Shi; Kim Tieu; Christine L Hammond
Journal:  Biol Chem       Date:  2009-03       Impact factor: 3.915

7.  Involvement of amino-acid side chains of membrane proteins in the binding of glutathione to pig cerebral cortical membranes.

Authors:  András Hermann; Vince Varga; Simo S Oja; Pirjo Saransaari; Réka Janáky
Journal:  Neurochem Res       Date:  2002-05       Impact factor: 3.996

Review 8.  Glutathione in Brain Disorders and Aging.

Authors:  Igor Y Iskusnykh; Anastasia A Zakharova; Dhruba Pathak
Journal:  Molecules       Date:  2022-01-05       Impact factor: 4.411

9.  Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study.

Authors:  Heba F Salem; Sayed M Ahmed; Ashraf E Hassaballah; Mahmoud M Omar
Journal:  Drug Des Devel Ther       Date:  2015-07-20       Impact factor: 4.162

10.  Central nervous system uptake of intranasal glutathione in Parkinson's disease.

Authors:  Laurie K Mischley; Kevin E Conley; Eric G Shankland; Terrance J Kavanagh; Michael E Rosenfeld; John E Duda; Collin C White; Timothy K Wilbur; Prysilla U De La Torre; Jeannie M Padowski
Journal:  NPJ Parkinsons Dis       Date:  2016-02-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.